Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 818585

Discovery of ‘click’ 1, 2, 3-triazolium salts as potential anticancer drugs


Steiner, Ivana; Stojanović, Nikolina; Bolje, Aljoša; Brozović, Anamaria; Polančec, Denis; Ambriović-Ristov, Andreja; Radić Stojković, Marijana; Piantanida, Ivo; Eljuga, Domagoj; Košmrlj, Janez; Osmak, Maja
Discovery of ‘click’ 1, 2, 3-triazolium salts as potential anticancer drugs // Radiology and oncology, 50 (2016), 3; 280-288 doi:10.1515/raon-2016-0027 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 818585 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Discovery of ‘click’ 1, 2, 3-triazolium salts as potential anticancer drugs

Autori
Steiner, Ivana ; Stojanović, Nikolina ; Bolje, Aljoša ; Brozović, Anamaria ; Polančec, Denis ; Ambriović-Ristov, Andreja ; Radić Stojković, Marijana ; Piantanida, Ivo ; Eljuga, Domagoj ; Košmrlj, Janez ; Osmak, Maja

Izvornik
Radiology and oncology (1318-2099) 50 (2016), 3; 280-288

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
triazoles ; triazolium salts ; anticancer activity ; cell cycle ; ROS

Sažetak
Background. In order to increase the effectiveness of cancer treatment, new compounds with potential anticancer activities are synthesized and screened. Here we present the screening of a new class of compounds, 1- (2-picolyl)-, 4-(2- picolyl)-, 1-(2-pyridyl)-, and 4-(2-pyridyl)-3- methyl-1, 2, 3-triazolium salts and ‘parent’ 1, 2, 3-triazole precursors. Methods. Cytotoxic activity of new compounds was determined by spectrophotometric MTT assay on several tumour and one normal cell line. Effect of the selected compound to bind double stranded DNA (ds DNA) was examined by testing its influence on thermal stability of calf thymus DNA while its influence on cell cycle was determined by flow cytometric analysis. Generation of reactive oxygen species (ROS) was determined by addition of specific substrate 5- (and-6)- chloromethyl-2’, 7’- dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA). Results. Parent triazoles were largely inactive, while some of the triazolium salts were highly cytotoxic for HeLa cells. Triazolium salts exhibited high cell- type dependent cytotoxicity against different tumour cells. Selected compound (4- (4- methoxyphenyl)-3- methyl-1-(2-picolyl)-1H-1, 2, 3-triazolium hexafluorophosphate(V) (2b) was significantly more cytotoxic against tumour cells than to normal cells, with very high therapeutic index 7.69 for large cell lung carcinoma H460 cells. Additionally, this compound was similarly cytotoxic against parent laryngeal carcinoma HEp-2 cells and their drug resistant 7T subline, suggesting the potential of this compound in treatment of drug resistant cancers. Compound 2b arrested cells in the G1 phase of the cell cycle. It did not bind ds DNA, but induced ROS in treated cells, which further triggered cell death. Conclusions. Our results suggest that the ‘click’ triazolium salts are worthy of further investigation as anti-cancer agents.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Biologija



POVEZANOST RADA


Projekti:
MZOS-098-0982913-2748 - Stanični odgovor na citotoksične spojeve i razvoj otpornosti (Osmak, Maja, MZOS ) ( CroRIS)
MZOS-098-0982913-2850 - Povećanje transdukcije adenovirusnih vektora i otpornost stanica na citostatike (Ambriović Ristov, Andreja, MZOS ) ( CroRIS)
MZOS-098-0982914-2918 - Dizajn, sinteza i ispitivanje interakcija malih molekula s DNA, RNA i proteinima (Piantanida, Ivo, MZOS ) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb,
KBC "Sestre Milosrdnice",
Dječja bolnica Srebrnjak

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Steiner, Ivana; Stojanović, Nikolina; Bolje, Aljoša; Brozović, Anamaria; Polančec, Denis; Ambriović-Ristov, Andreja; Radić Stojković, Marijana; Piantanida, Ivo; Eljuga, Domagoj; Košmrlj, Janez; Osmak, Maja
Discovery of ‘click’ 1, 2, 3-triazolium salts as potential anticancer drugs // Radiology and oncology, 50 (2016), 3; 280-288 doi:10.1515/raon-2016-0027 (međunarodna recenzija, članak, znanstveni)
Steiner, I., Stojanović, N., Bolje, A., Brozović, A., Polančec, D., Ambriović-Ristov, A., Radić Stojković, M., Piantanida, I., Eljuga, D., Košmrlj, J. & Osmak, M. (2016) Discovery of ‘click’ 1, 2, 3-triazolium salts as potential anticancer drugs. Radiology and oncology, 50 (3), 280-288 doi:10.1515/raon-2016-0027.
@article{article, author = {Steiner, Ivana and Stojanovi\'{c}, Nikolina and Bolje, Aljo\v{s}a and Brozovi\'{c}, Anamaria and Polan\v{c}ec, Denis and Ambriovi\'{c}-Ristov, Andreja and Radi\'{c} Stojkovi\'{c}, Marijana and Piantanida, Ivo and Eljuga, Domagoj and Ko\v{s}mrlj, Janez and Osmak, Maja}, year = {2016}, pages = {280-288}, DOI = {10.1515/raon-2016-0027}, keywords = {triazoles, triazolium salts, anticancer activity, cell cycle, ROS}, journal = {Radiology and oncology}, doi = {10.1515/raon-2016-0027}, volume = {50}, number = {3}, issn = {1318-2099}, title = {Discovery of ‘click’ 1, 2, 3-triazolium salts as potential anticancer drugs}, keyword = {triazoles, triazolium salts, anticancer activity, cell cycle, ROS} }
@article{article, author = {Steiner, Ivana and Stojanovi\'{c}, Nikolina and Bolje, Aljo\v{s}a and Brozovi\'{c}, Anamaria and Polan\v{c}ec, Denis and Ambriovi\'{c}-Ristov, Andreja and Radi\'{c} Stojkovi\'{c}, Marijana and Piantanida, Ivo and Eljuga, Domagoj and Ko\v{s}mrlj, Janez and Osmak, Maja}, year = {2016}, pages = {280-288}, DOI = {10.1515/raon-2016-0027}, keywords = {triazoles, triazolium salts, anticancer activity, cell cycle, ROS}, journal = {Radiology and oncology}, doi = {10.1515/raon-2016-0027}, volume = {50}, number = {3}, issn = {1318-2099}, title = {Discovery of ‘click’ 1, 2, 3-triazolium salts as potential anticancer drugs}, keyword = {triazoles, triazolium salts, anticancer activity, cell cycle, ROS} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font